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Abstract
Introduction: Nelson’s syndrome (NS) is a rare clinical syndrome caused by an enlarging, aggressive corticotroph pituitary adenoma that 
can occur following bilateral adrenalectomy performed in the treatment of refractory Cushing’s disease (CD). Such tumours respond 
poorly to currently available therapeutic options, which include surgery, radiotherapy, pharmacotherapy, and chemotherapy. They are 
a challenging problem in neurosurgical practice. The aim of this work was to evaluate the early and long-term results of microsurgery in 
a single surgeon’s series of patients with NS. 
Material and methods: During the period from January 2000 to December 2005, 10 patients with NS underwent surgery. The authors 
analysed surgical outcomes in the NS group of seven women and three men with the mean age of 47.99 years (range 39–66, SD ± 8.47 
years). NS was diagnosed based on clinical signs and symptoms, especially hyperpigmentation of the skin, elevated serum ACTH levels, 
and pituitary tumour growth. Parasellar extension of the adenomas was assessed in both groups according to Knosp’s and Hardy-Wilson 
classifications. Pituitary function and radiographs were evaluated in the early postoperative period, 30 days after the operation, and dur-
ing follow-up. Histological examination was based on the WHO (2004) criteria.
Results: According to the criteria for Nelson’s syndrome remission, five patients (50%) were cured. No perioperative mortality was reported. 
Three patients developed pituitary insufficiency and two patients developed diabetes insipidus. There was one case of postoperative 
cerebrospinal fluid leakage. One patient was diagnosed with pituitary carcinoma.
Conclusions: Transsphenoidal microsurgical removal of pituitary adenomas is a safe and effective treatment of Nelson’ syndrome. 
(Endokrynol Pol 2015; 66 (6): 504–513)
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Streszczenie
Wstęp: Zespół Nelsona (NS) to rzadko występująca jednostka chorobowa spowodowana agresywnym, inwazyjnym rozrostem gruczolaka 
kortykotropowego przysadki u pacjentów podanych obustronnej ratunkowej adrenalektomii w następstwie przetrwałej choroby Cushinga. 
Skuteczność dostępnym metod terapeutycznych: leczenia chirurgicznego, radioterapii, leczenia farmakologicznego i chemioterapii jest 
w tych przypadkach ograniczona. Leczenie chorych z NS pozostaje wyzwaniem w praktyce neurochirurgicznej.
Celem pracy była ocena wczesnych i odległych wyników leczenia mikrochirurgicznego gruczolaków kortykotropowych przebiegających 
z objawami NS.
Materiał i metody: Analizie poddano wyniki 10 chorych (7 kobiet i 3 mężczyzn, średnia wieku 47,99 lat (w zakresie 39–66, SD ± 8.47 lat) 
operowanych w okresie od stycznia 2000 do grudnia 2005 roku przez jednego chirurga. Zespół Nelsona rozpoznano na podstawie obja-
wów klinicznych (hiperpigmentacji skóry i błon śluzowych), wyników badań biochemicznych (wysokie wartości ACTH w surowicy) oraz 
wzrostu gruczolaka przysadki. Okołosiodłowy rozrost guza przysadki oceniano na podstawie skali Knospa i Hardyego-Wilsona. Czynność 
hormonalną przysadki analizowano we wczesnym okresie pooperacyjnym, 30 dni po operacji oraz w okresie obserwacji odległej. Ocenę 
histopatologiczną przeprowadzono według wytycznych klasyfikacji WHO (2004).
Wyniki: Remisję zespołu Nelsona uzyskano u 5 chorych. W analizowanej grupie nie było powikłań śmiertelnych w okresie okołoope-
racyjnym. Po operacji w 3 przypadkach wystąpiła niedoczynność przysadki, a moczówka prosta u 2 chorych. W jednym przypadku po 
operacji wystąpił płynotok pooperacyjny. U jednej chorej w okresie obserwacji stwierdzono ewolucję guza w rak przysadki. 
Wnioski: Leczenie mikrochirurgiczne gruczolaków przysadki w NS jest metodą skuteczną i bezpieczną. (Endokrynol Pol 2015; 66 (6): 504–513)
Słowa kluczowe: gruczolak przysadki; ACTH; chirurgia przezklinowa; zespół Nelsona
Introduction
In 1958, Nelson et al. described the case of a female 
patient with ACTH-producing pituitary tumour growth 
following adrenalectomy for Cushing`s disease (CD) 
[1]. Since that time, so-called “Nelson’s syndrome” is 
defined as the signs and symptoms associated with 
pituitary corticotroph tumour growth that develops 
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The diagnosis of Nelson’s syndrome was based on 
plasma ACTH levels higher than or equal to 200 pg/mL 
measured 24 hours after withdrawal of glucocorticoid 
replacement therapy and MRI evidence of pituitary 
tumour re-growth. 
Surgical procedure
The microsurgical transseptal transsphenoidal ap-
proach without fluoroscopy was routinely used for 
resection of corticotroph pituitary adenomas. The 
sella was exposed and an H-shaped incision of the 
dura was made. The dura mater was opened and 
separated from the pituitary capsule to expose the 
entire anterior surface of the pituitary gland. The 
pituitary gland was carefully explored, irrespective 
of preoperative MRI findings. In patients with in-
vasive macroadenomas with intracranial expansion 
the transcranial (unilateral transfrontal or fronto-
temporal) approach was used. The side on which the 
operation was performed was chosen on the basis of 
the lateral extension of the tumour. In all cases selec-
tive adenomectomy with preservation of the normal 
pituitary tissue was attempted. 
Preoperative MRI
All patients underwent high-resolution MRI scans of 
the pituitary-hypothalamic region (Signa, GE Medical 
System; 1.5 T). MRI scans were performed before and 
after intravenous administration of Gd-DTPA. Micro-
adenoma was defined as a pituitary tumour of less than 
10 mm in any dimension, whereas macroadenoma was 
defined as a pituitary tumour with at least one diameter 
greater than or equal to 10 mm. The perisellar extension 
of the tumour was evaluated in each case. All tumours 
were classified according to the Knosp’s scale as well as 
the modified Hardy-Wilson radiographic classification
Immunohistochemical and ultrastructural  
assessment
In all cases the surgical tissue samples were collected 
for pathological examination and routinely stained with 
haematoxylin and eosin (H&E). Immunohistochemi-
cal staining was performed on paraffin-embedded 
specimens with the EnVision Flex Visualisation System 
(Dako, K8000) with DAB as the chromogen and antibod-
ies against all anterior pituitary hormones (LabVision), 
and the glycoprotein α-subunit (Novocastra). 
For ultrastructural examination, small blocks of tis-
sue were fixed in 2.5% glutaraldehyde and post-fixed in 
1% osmium tetroxide, dehydrated in graded alcohols, 
and embedded in Epon 812. Ultrathin sections were 
counterstained with uranyl acetate and lead citrate. In 
all cases a CM120 BioTween Philips electron microscope 
was used for ultrastructural examination.
after bilateral adrenalectomy in CD patients. The syn-
drome is characterised by hyperpigmentation of the 
skin and mucous membranes associated with excess 
ACTH secretion and neurological symptoms resulting 
from mass effect [2].
Despite constant progress in neurosurgical opera-
tive techniques and pituitary-targeted medical therapy 
of corticotroph tumours, bilateral adrenalectomy is still 
the definitive, lifesaving treatment in difficult cases of 
CD. Its main advantage is immediate elimination of 
hypercortisolaemia and a rapid improvement in its 
clinical symptoms. However, the procedure results 
in permanent adrenal insufficiency, which requires 
lifelong hydrocortisone replacement therapy [3, 4]. 
As mentioned before, it may be also complicated by 
the development of NS due to corticotroph tumour 
progression. 
The treatment of choice in NS consists of attempting 
to surgically remove the tumour via the transsphenoidal 
approach [5]. Frequently, however, the surgery is not 
radical, which is due to the same anatomical condi-
tions that prevented complete curative surgery for 
pre-existing CD [3, 4]. 
The aim of this study was to evaluate the early and 
long-term results of the microsurgical treatment of pa-
tients with NS in a single neurosurgical centre.
Material and methods
Study population
Out of 133 patients operated on for Cushing’s disease 
in the Department of Neurosurgery between 2000 and 
2005 we retrospectively selected 10 patients (seven 
women and three men; F:M ratio: 2.3:1) with confirmed 
NS (mean age 47.9 ± 8.5 years; range 39–66 years). All 
of them were operated on by the same neurosurgeon 
using the same surgical protocol. The follow-up was 
45.3 ± 17.8 months (range 10–71 months).
All patients had been informed about the aims and 
methods of the study and they had signed the informed 
consent. The study protocol was approved by the Ethics 
Committee at the Military Institute of Medicine.
Clinical course of the disease
All patients underwent a standard clinical evaluation. 
Particular attention was devoted to the clinical course of 
the disease and its complications: the age at the onset of 
hypercortisolaemia, symptom duration, previous treat-
ment for CD, the age at which bilateral adrenalectomy 
was performed, and time of NS development after ad-
renalectomy. The function of the anterior pituitary was 
assessed according to standard hormonal criteria. The 
diagnosis of diabetes insipidus was based on the pres-
ence of polyuria and positive water depravation test.
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The pathological assessment was performed based 
on the 2004 World Health Organisation (WHO) diag-
nostic criteria.
Criteria of cure
Following the surgical procedure, all patients were 
subjected to further postoperative evaluation, which 
included plasma ACTH and serum cortisol measure-
ments. MRI scans of the pituitary were also obtained 
in all cases. After the operation, the patients were 
regarded as cured if they met the following criteria 
for remission: morning plasma ACTH concentration 
below 200 pg/mL determined 24 hours after discon-
tinuation of hydrocortisone replacement therapy, 
with no MRI evidence of a tumour in the pituitary 
gland. 
Hormone assay
Plasma ACTH levels were measured using a specific 
two-step radioimmunometric assay (IRMA; coated tube 
technique; Brahms, Germany). Method sensitivity was 
1.2 pg/mL and the reference range was 10–60 pg/mL. 
Chemiluminescent immunometric assays (IMMULITE 
2000; Siemens, Great Britain) were used to measure 
serum cortisol. Method sensitivity was 0.2 μg/dL 
(5.5 nmol/L). The normal range for cortisol levels was 
5–25 μg/dL (138–690 nmol/L). 
Visual assessment 
All patients underwent routine eye examinations pre- 
and postoperatively. Visual acuity was assessed using a 
Snellen’s chart, and visual fields were measured using 
manual and computerised perimetry. Fundoscopy was 
performed in all patients.
Statistical analysis
Methods of descriptive statistics (mean, median, 
standard deviation, proportion) were employed in the 
statistical analysis. Tested hypotheses concerning the 
relationship between two categorical variables were 
expressed as frequencies and compared using the 
exact chi-square test (Fisher ’s exact test). The signifi-
cance of differences between the two groups in terms 
of mean values of continuous variables was analysed 
by means of Student`s t-test for a normal distribu-
tion and the Mann-Whitney U test for small samples 
when its distribution was not normal. Verification of 
hypotheses concerning comparisons of the analysed 
parameters in two time points was conducted using 
the Wilcoxon test for small samples (for non-normal 
distributions). 
The level of significance was set at P < 0.05. The 
calculations were made using the commercially avail-
able statistical software package SPSS v.18.0.
Results
Detailed results of clinical and epidemiological 
assessments of the study population, including de-
mographic characteristics, pre-operative hormone 
levels, and MRI scans of the pituitary, are presented 
in Tables I, II.
Table I. Demographic data and preoperative clinical characteristics of the study group of 10 patients with NS
Tabela I. Dane demograficzne i przedoperacyjne wyniki badań w analizowanej grupie chorych z zespołem Nelsona
Patient Age Sex Age of the 
onset of 
hipercor-
tisolemia 
(years)
Duration of 
the symptoms 
of hipercor-
tisolemia 
before confir-
mation of CD 
(months)
Age of the 
biletaral 
adrenalectomy 
(years)
Time of the 
occurrence 
of NS 
symptoms 
after adre-
nalectomy 
(months)
Visual dis-
turbances
Preoperative pituitary  
function
Num-
ber of 
pituitary 
ad-
enoma 
opera-
tions
Time 
of the 
fol-
low-
up
Secondary 
hypothyroid-
ism
Hypog-
onado-
tropic 
hypog-
onadism
1 40 M 13 18 16 36 – – – 1xTS 71
2 45 K 30 10 32 12 – – – 1xTS 57
3 42 M 30 9 31 9 + – + 1xTS, 1xTK 47
4 66 K 32 24 33 9 – – – 1xTS 50
5 50 M 20 36 21 108 – – – 1xTS 50
6 53 K 33 60 34 6 – – – 1xTS 48
7 46 K 24 18 25 24 + + – 2xTS, 1xTK 36
8 56 K 26 6 27 6 – – – 1xTS 10
9 42 K 17 6 17 18 + + – 1xTK 24
10 39 K 39 18 41 12 – – – 1xTS 60
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Clinical and epidemiological assessment
The mean age at onset of symptoms in the stud-
ied group of patients was 26.4 ± 7.99 years (range: 
13–39 years). The mean period of time from diagnosis 
of Cushing’s disease to bilateral adrenalectomy was 
16.2 ± 8.97 months (range 6–36 months), whereas the 
mean age of patients undergoing this procedure was 
27.7 ± 8.02 years (range 16–41 years) (Table I). 
The mean period of time between bilateral adrenal-
ectomy and the onset of NS symptoms was 24 ± 30.95 
months (range 6–108 months). The obtained values did not 
differ between the subgroups of female and male patients.
Preoperative hormone evaluation
The mean preoperative plasma ACTH level in the study 
group was 15574.4 ± 27021.9 pg/mL (range: 894–87500 
pg/mL). The mean ACTH concentration in the subgroup 
of female patients was 2.1 times higher than that in male 
patients, although the difference was not significant 
(18 527.7 ± 31 890.6 pg/mL in females vs. 8686.7 ± 
11 536.6 pg/mL in males; P = 0.9). In all patients the 
morning serum cortisol level was lower than 1.0 μg/dL. 
Detailed results of hormone evaluation are presented 
in Table II. We confirmed a positive (r = 0.58, P < 0.05) 
correlation between the preoperative ACTH concentra-
tion and adenoma volume. 
Of note, in terms of anterior pituitary function, is 
that in two patients we observed signs of secondary hy-
pothyroidism that required replacement therapy with 
L-thyroxin. Gonadotrophic function of the pituitary 
was impaired only in one patient with a giant pituitary 
tumour. The remaining nine patients had normal pitui-
tary gonadotropic function. Three of the seven women 
with NS (43%) had regular menses. 
None of the studied patients showed symptoms 
of diabetes insipidus before surgical treatment for NS. 
Preoperative MRI scans
Pituitary tumour was precisely visualised in all patients 
based on MRI. Macroadenomas were found in nine 
cases and microadenoma in one case (Table III).
The mean maximum diameter of the pituitary tumour 
was 21.4 ± 15.4 mm (median: 16.2 mm range: 7.7–52.7 mm). 
The mean adenoma volume was 13 170 ± 24 527.3 mm3 
(median: 2125.8 mm3; range 234.6–72 812.6 mm3). 
We did not confirm a statistically significant difference 
between the mean tumour volume in the subgroup of 
female and male patients (8106.7 ± 15 184.5 mm3 vs. 
24 984.8 ± 41 428.9 mm3, respectively; P = 0.1). However, 
it should be noted that in male patients it was 3.1 times 
higher than in female patients. The tumours displayed 
perisellar growth accompanied by cavernous sinus 
invasion. Invasive macroadenomas were found in nine 
of the ten patients (90%) (Fig. 1). Ta
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Ophthalmological assessment
Preoperatively, three patients (No. 3, 7, and 9) were 
diagnosed with visual disturbances in the form of dete-
rioration of visual acuity and visual field deficits due to 
suprasellar growth of pituitary tumours (Table I, Fig. 2). 
Histopathological and immunohistochemical 
evaluation
The histopathological and immunohistochemical exam-
ination of the surgically removed specimens revealed 
the presence of corticotroph adenoma in all 10 cases.
In four cases an ultrastructural examination with 
electron microscopy was performed and revealed 
densely granulated ACTH adenomas (DG-ACTH). 
In five cases the presence of the Ki-67 antigen was 
assessed using MIB-1 antibodies. In four patients, the 
MIB-1 index was lower than 3%. In one patient (case 
No. 7) the MIB-1 index was higher than 3% and was 
accompanied by high p53 nuclear protein expression. 
This patient was diagnosed with atypical corticotroph 
adenoma.
The results of pathological examination are pre-
sented in detail in Table II and Figures 3, 4. 
Evaluation of postoperative complications
There were no fatal complications in the perioperative 
period, i.e. within the first 30 days after performed 
surgery. In total, three deaths occurred throughout 
the follow-up period (Table I, II). Patient No. 2 died 
57 months after surgery due to cardiovascular and 
metabolic complications of poorly controlled diabetes. 
Patient No. 3 died after 47 months of follow-up as 
a result of invasive adenoma infiltrating the skull base. 
The third patient (No. 9) died 37 months after pituitary 
surgery in a different centre. The cause of death was 
not known.
In all 10 cases selective adenomectomy was per-
formed. It led to thyrotrophic and gonadotropic pitui-
tary insufficiency in three patients. Two patients (20%) 
were diagnosed with transient diabetes insipidus, and 
an additional two patients (20%) with persistent ADH 
insufficiency. 
Intraoperative CSF leakage occurred in four patients 
(40%). The patients underwent sellar floor reconstruc-
tion during the initial operation. In three cases water-
tight closure of the intracranial space was achieved. 
In one case, during the early postoperative period (20 
days following the surgical procedure), CSF leakage 
was observed without signs of meningitis. The patient 
underwent a subsequent surgery resulting in achieve-
ment of watertight closure of the intracranial space 
without additional complications.
Effectiveness of surgical treatment 
All of the patients in the study group were treated sur-
gically. In the study group there was not a single case 
treated by radiotherapy. These ten patients underwent 
a total of 13 operations. The transsphenoidal approach 
was the most common technique and was performed 
10 times (nine surgeries via the transseptal transsphe-
noidal approach, and one via the right-sided lateral 
rhinotomy). Transcranial surgeries were performed in 
three cases (two fronto-temporal and one unilateral 
trans-frontal craniotomies).
Table III. Demographic data and neuroradiological assessment of the pituitary adenomas of the study group of 10 patients with NS
Tabela III. Dane demograficzne i charakterystyka radiologiczna wzrostu gruczolaków kortykotropowych w analizowanej 
grupie chorych z zespołem Nelsona
Patient Age Sex Size of the 
tumor
Diaameters of the 
tumor [mm]
Mean diameter 
of the pituitary 
adenoma [mm]
Volume of 
the pituitary 
adenoma [mm3]
Perisellar growth/invasion
Knosp’s scale Hardy-Wilson’s classification
Grade Stage
1 40 M M 20 × 14 × 13 15,67 1905,9 IIo III A
2 45 K M 14 × 16 × 20 16,67 2345,7 IVo III E
3 42 M M 66 × 49 × 43 52,67 72812,6 IVo IV E
4 66 K M 17 × 18 × 22 19 3524,9 IVo IV E
5 50 M m 7 × 8 × 8 7,67 234,6 IIo III 0
6 53 K M 15 × 10 × 7 10,67 549,8 IIIo II A
7 46 K M 64 × 34 × 37 45 42155,9 IVo IV E
8 56 K M 10 × 12 × 12 11,33 753,9 IIo II 0
9 42 K M 35 × 25 × 15 25 6872,2 IVo IV E
10 39 K M 13 × 10 × 8 10,33 544,5 IIo III E
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In eight patients the operation was to be inherently 
radical and was undertaken with curative intent. In the 
two remaining cases, the performed surgical procedures 
were palliative in nature and their purpose was to re-
duce tumour volume, and improve neurological status 
and quality of life.
Because of the diversity of the surgical approaches 
used, we decided not to conduct an assessment of early 
results of surgical treatment. Detailed long-term results 
of surgical treatment were obtained during follow-up.
Five patients (50%) achieved a sustained reduction 
in ACTH concentration to values below 200 pg/mL 
and no remnants of pituitary tumour were visible on 
postoperative MRI. It was accompanied by a decrease 
in the intensity of skin hyperpigmentation. This group 
included one patient with microadenoma and four 
patients with macroadenomas, with limited perisellar 
expansion (grade II and III according to Knosp’s scale). 
In the remaining five patients the neurosurgical 
treatment was not curative. Instead, its purpose had 
been to improve the patients` neurological condition. 
Severe growth and infiltration of cranial base structures, 
primarily the cavernous sinus, constituted the reason 
for incomplete removal of the pituitary tumours. Grade 
IV tumours (Knosp’s scale) with infiltration of the 
cavernous sinus were identified in all cases that failed 
to be cured.
The extent of perisellar growth, as measured by 
Knosp’s scale, was established to be the main factor 
influencing the effectiveness of NS surgical treatment.
The surgical treatment resulted in visual field wid-
ening and acuity improvement only in case No. 9. In 
patients No. 3 and 7 no improvement was observed, 
despite significant decrease in tumour volume. 
Six months after surgery, a 46-year-old female 
(patient No. 7) developed acute deterioration of visual 
acuity with accompanying limitation of visual field 
in all quadrants. Subsequent surgery attempts failed 
to improve her vision. In case No. 3 re-growth of an 
invasive pituitary tumour caused serious visual de-
terioration and paresis of both abducens and the left 
oculomotor nerves.
Discussion
Diagnosis and treatment of NS remains one of the great-
est challenges of contemporary endocrinology [6]. This 
rare form of CD is caused by ACTH-secreting pituitary 
adenoma with unpredictable, usually aggressive clini-
cal course that often leads to serious, life-threatening 
complications [3, 7]. Diagnostic criteria for NS were 
proposed in 1958 and originally included: abnormally 
high plasma ACTH, enlargement of the sella turcica 
shown in X-ray of the skull, vision disturbances re-
Figure 1. Coronal T1 weighted after Gd-DTPA magnetic resonance imaging (preoperative and postoperative) of the aggressive ACTH-
secreting pituitary tumour invading the left cavernous sinus (Knosp IVo) with encasement of the left cavernous carotid artery and 
erosion of the sellar floor.
Rycina 1. Inwazyjny gruczolak kortykotropowy naciekający lewą zatokę jamistą (Knosp IVo) i niszczący dno siodła tureckiego (wynik 
przedoperacyjny i pooperacyjny badania MR po podaniu środka kontrastowego, przekrój czołowy, czas T1-zależny)
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Figure 2. Preoperative and postoperative MRI of 
the sellar region (coronal and sagittal T1-weighted 
before and after Gd-DTPA administration) revealed 
an invasive tumour mass with parasellar extension 
and right cavernous sinus invasion (Knosp IVo). 
Optic chiasm is compressed and displaced
Rycina 2. Inwazyjny gruczolak kortykotropowy 
charakteryzujący się wzrostem okołosiodłowym, 
naciekający prawą zatoke jamistą (Knosp IVo) 
i uciskający oraz przemieszczający skrzyżowanie 
wzrokowe (wynik przedoperacyjny i pooperacyjny 
badania MR po podaniu środka kontrastowego, 
przekrój czołowy i strzałkowy, czas T1-zależny)
Figure 3. Electron microphotograph (12500×) of the densely 
granulated corticotroph adenoma (DG-ACTH) in Nelson’s 
syndrome. The big, ovoid nuclei is seen. The cytoplasm is abundant 
and possesses RER membranes, a prominent Golgi apparatus, 
and many secretory granules in the size range of 200 to 500 nm
Rycina 3. Bogatoziarnisty gruczolak kortykotropowy w zespole 
Nelsona. Widoczne duże, owalne jadra komórkowe. Rozbudowana 
cytoplasma, siateczka cytoplasmatyczna oraz aparat Golgiego 
z widocznymi licznymi ziarniostościami wewnątrzwydzielniczymi 
o średnicy 200–500 nm. Badanie mikroskopii elektronowej, 
powiekszenie 12500×
sulting from compression of the optic chiasm by the 
enlarging pituitary tumour, and hyperpigmentation of 
the skin and mucous membranes [1, 2]. 
Kemink et al. suggested other clinical characteristics 
of NS [5]. They defined NS based on plasma ACTH 
concentration measured 24 hours after discontinuation 
of hydrocortisone replacement therapy. They adopted 
the plasma ACTH level of 200 pg/mL as the lower 
cut-off point in NS. Furthermore, they recognised the 
detection of pituitary macroadenoma in MRI as a nec-
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essary condition for NS diagnosis [5]. However, this 
last issue remains particularly controversial. While 
most authors indeed report invasive macroadenomas 
while presenting cases of patients with NS [8–10], other 
authors emphasise that in 20–40% of cases the condi-
tion is associated with pituitary microadenomas [7, 11, 
12]. Notably, the efficacy of surgical treatment of small 
tumours is much higher when compared to the results 
achieved in cases of invasive macroadenomas [7, 8].
In our own material, microadenoma was identified 
only in one of the ten patients with NS. However, remis-
sion was achieved only in patients with smaller pitui-
tary tumours and limited, intrasellar expansion. In the 
case of invasive macroadenoma the results of surgical 
treatment were definitely worse. We still considered this 
case to be a partial success due to the achieved vision 
improvement through optic chiasm decompression.
Tindal et al. achieved similar results [13]. In their 
study the main predictive factor of radical surgery was 
tumour size, assessed according to the Hardy-Wilson 
classification. The authors also reported that the extent 
of suprasellar expansion did not limit the transsphenoi-
dal approach, but the presence of infiltration of adjacent 
structures, in particular the cavernous sinus, limited the 
effectiveness of treatment [13].
In earlier publications, the incidence of NS was es-
timated at 3–42% in adults [9, 11, 15] and at 25–66% in 
children [4, 14]. In one of the largest research studies on 
NS with long-term follow-up, conducted in a group of 
37 patients Kasperlik-Zaluska et al. indicated a signifi-
cantly higher incidence of NS, reaching up to 71% [7]. 
Kelly et al. identified corticotroph tumour in 24 out of 46 
patients (52%) after bilateral adrenalectomy [9]. Similar 
rates were also reported by other authors [2, 4, 10]. Assie 
et al. suggested assessing the change in corticotroph 
tumour size (CTP, Corticotroph Tumour Progression) 
to monitor patients with Cushing’s disease following 
therapeutic bilateral adrenalectomy [3]. According to 
these authors, pituitary tumour enlargement typically 
precedes development of Nelson’s syndrome (elevated 
ACTH levels, skin hyperpigmentation, visual distur-
bances) and is a definitive sign of corticotroph adenoma 
growth and transformation into an invasive, aggressive 
pituitary neoplasm [3]. Therefore, the higher incidence 
of CTP and NS reported in newer studies probably 
results from improved pituitary tumour visualisation 
techniques, particularly MRI, which is commonly used 
in neuroradiological diagnostics. 
In light of the already mentioned reports by Kasper-
lik-Zaluska et al. and Assie et al. we can conclude that 
prognostic factors for pituitary tumour growth and 
NS development include: short history (rapid course 
of the disease), age at the onset of CD, high (over 
1000 pg/mL) ACTH concentration measured two hours 
after the administration of the morning hydrocortisone 
replacement dose, and MRI evidence of a pituitary 
tumour prior to bilateral adrenalectomy [3, 7]. Thus, 
in patients with visible, inoperable or incompletely 
removed pituitary tumour the decision to perform 
bilateral adrenalectomy should be made with particular 
caution. In such cases one should consider using ste-
reotactic radiotherapy or radiosurgery and/or extended 
treatment with an adrenal steroidogenesis inhibitor 
(ketoconazole, metyrapone, or mitotane) [3, 7, 16].
These observations were confirmed by Fisher et 
al., who demonstrated a more aggressive course of the 
disease and rapid expansion of pituitary adenomas in 
patients under 20 years of age [17]. Identical conclusions 
were also reported by other authors, who observed 
a higher risk of Nelson’s syndrome and a more aggres-
sive course of the disease in children [18, 19]. In con-
trast, Pereira et al. failed to demonstrate a relationship 
between the younger age of CD patients and the risk 
of NS occurrence in a group of 30 patients with NS [10].
In our material the mean period from bilateral adre-
nalectomy to NS diagnosis was 24 months and ranged 
from 6 to 108 months. There were no confirmed gender 
differences with regard to NS incidence in the analysed 
group. The time of NS development after bilateral 
adrenalectomy is of great importance for the proper 
planning of post-operative follow-up. However, in 
Figure 4. Electron microphotograph (12500×) of the sparsely 
granulated corticotroph adenoma (SG-ACTH) in Nelson’s syndrome. 
There are numerous mitochondria and well developer Golgi complex 
in the adenoma cells. Spherical secretory granules (vary in electron 
density) line up along the cell membranes. A scattered chromatin and 
single nucleoli are seen in large ovoid nuclei.
Figure 4. Ubogoziarnisty gruczolak kortykotropowy 
w zespole Nelsona. W komórkach widoczne liczne mitochondria 
i rozbudowany aparat Golgiego. Wzdłuż błon komórkowych 
ułożone okrągłe ziarnistości wydzielnicze o zdróżnicowanej 
gęstości elektronowej. Duże jądra komórkowe z rozproszoną 
cytoplasmą i pojedynczymi jąderkami. Badanie mikroskopii 
elektronowej, powiekszenie 12500×
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accordance with the opinion of most authors, an accu-
rate prediction of the NS onset is not possible. Moreover, 
NS can occur at any time, regardless of any possible 
methods of prevention [3, 9]. Kasperlik-Załuska et al. 
observed NS development within the period of 1 to 
18 years after bilateral adrenalectomy [7]. Lüdecke et al. 
presented similar data [20]. Kemink et al. reported an 
extreme case of NS with pituitary tumour enlargement 
accompanied by skin hyperpigmentation even 29 years 
after adrenalectomy [21]. However, the greatest risk of 
Nelson syndrome exists within the first three years after 
adrenal gland removal, and it definitely decreases after 
seven years [3, 12].
The results of surgical treatment of NS are vastly 
inferior to those observed with other types of pituitary 
tumours [5, 7]. Most authors emphasise the fact that 
the tumours in this disease are mostly macroadeno-
mas and are characterised by infiltration of adjacent 
structures, especially the cavernous sinus [22, 23, 24]. 
Kemink et al. reported infiltration into the cavernous 
sinus in 9 of 15 observed patients (60%) [5]. Assie et al. 
and Xing et al. reported a lower incidence of cavernous 
sinus invasion [3, 12]. Other authors have pointed out 
that the main factor influencing the effectiveness of 
surgical treatment, and highly important in terms of 
prognosis, is the degree of extrasellar expansion [3, 25]. 
Suprasellar growth together with visual disturbances 
resulting from optic chiasm compression occurs quite 
frequently in NS [5, 7]. Lüdecke et al. reported this in 
31% of patients [20].
In the presented study, macroadenoma was detected 
in 9 of the 10 patients. Radiographic evidence of cavern-
ous sinus invasion was detected in all patients from our 
group. Visual disturbances were identified in 3 of the 
10 patients (30%). 
Neurosurgical treatment of NS helps achieve remis-
sion in just 20–30% of patients [12, 26, 27]. Significant 
size and advanced perisellar expansion of adenomas 
are the reasons for low effectiveness of this form of 
treatment [20, 28].
Encouraging outcomes of surgical treatment were 
presented by Fukushima, who achieved remission in 
7 out of 10 patients; however, all tumours in that 
study were characterised by intrasellar expansion only 
[11]. Similar results were also published by Lüdecke 
et al. [20]. De Tommasi et al. achieved normalisation of 
ACTH levels only in 16.6% of operated patients with 
NS [8]. Kemink et al. reported remission of NS in 5 out 
of 11 patients (45%) [5]. Xing et al. confirmed a com-
plete tumour removal in 56% of patients [12]. All of the 
authors cited above emphasised the fact that tumours 
characterised by smaller size and intrasellar expansion 
have a more favourable prognosis and lower incidence 
of postoperative complications [5, 7, 9, 12, 20]. In our 
group – based on adopted criteria – we considered five 
patients (50%) to be in remission of NS. 
Three patients (30%) from our study group were 
diagnosed with anterior pituitary insufficiency, whereas 
two patients (20%) were diagnosed with permanent 
diabetes insipidus. CSF leakage occurred in one patient 
and required reconstruction of the sellar floor. Lüdecke 
et al. reported only one case of pituitary insufficiency 
[20] Xing et al. listed only oculomotor nerve injury 
among complications related to surgical treatment in 
23 patients with NS, but there was no information re-
garding postoperative pituitary function [12]. Kemink 
et al. reported one (9%) case of pituitary insufficiency 
and two (18%) cases of persistent diabetes insipidus 
[5]. Kelly et al. reported five cases of persistent diabetes 
insipidus (38.5%) and nine cases of new-onset anterior 
pituitary insufficiency (69%) [9].
Conclusions
Successful treatment of NS remains a challenge. 
Our results confirm that microsurgical treatment is 
a relatively effective and safe procedure, although the 
outcomes are worse in comparison to those achieved 
in other types of pituitary tumours. Our data sup-
port the view that a more favourable prognosis is 
attributed to cases of microadenomas and intrasellar 
macroadenomas. On the contrary, extrasellar growth 
with cavernous sinus involvement is the main factor 
negatively influencing the effectiveness of surgical 
treatment. Additionally, a long-term endocrinological 
follow-up is necessary for an accurate assessment of 
postoperative complications in NS, especially in terms 
of pituitary insufficiency.
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